Williams Lanie A, Hamilton Matthew C, Edin Matthew L, Lih Fred B, Eccles-Miller Jazmine A, Tharayil Nishanth, Leonard Elizabeth, Baldwin William S
Biological Sciences, Clemson University, Clemson, SC 29634, USA.
Division of Intramural Research, National Institute of Environmental Health Sciences, National Institute of Health, Research Triangle Park, Washington, NC 27709, USA.
Toxics. 2024 Jan 26;12(2):106. doi: 10.3390/toxics12020106.
Perfluorooctanesulfonate (PFOS) is a widespread environmental pollutant with a long half-life and clearly negative outcomes on metabolic diseases such as fatty liver disease and diabetes. Male and female Cyp2b-null and humanized CYP2B6-transgenic (hCYP2B6-Tg) mice were treated with 0, 1, or 10 mg/kg/day PFOS for 21 days, and surprisingly it was found that PFOS was retained at greater concentrations in the serum and liver of hCYP2B6-Tg mice than those of Cyp2b-null mice, with greater differences in the females. Thus, Cyp2b-null and hCYP2B6-Tg mice provide new models for investigating individual mechanisms for PFOS bioaccumulation and toxicity. Overt toxicity was greater in hCYP2B6-Tg mice (especially females) as measured by mortality; however, steatosis occurred more readily in Cyp2b-null mice despite the lower PFOS liver concentrations. Targeted lipidomics and transcriptomics from PFOS-treated Cyp2b-null and hCYP2B6-Tg mouse livers were performed and compared to PFOS retention and serum markers of toxicity using PCA. Several oxylipins, including prostaglandins, thromboxanes, and docosahexaenoic acid metabolites, are associated or inversely associated with PFOS toxicity. Both lipidomics and transcriptomics indicate PFOS toxicity is associated with PPAR activity in all models. GO terms associated with reduced steatosis were sexually dimorphic with lipid metabolism and transport increased in females and circadian rhythm associated genes increased in males. However, we cannot rule out that steatosis was initially protective from PFOS toxicity. Moreover, several transporters are associated with increased retention, probably due to increased uptake. The strongest associations are the organic anion transport proteins () genes and a long-chain fatty acid transport protein (), enriched in female hCYP2B6-Tg mice. PFOS uptake was also reduced in cultured murine hepatocytes by OATP inhibitors. The role of OATP1A6 and FATP1 in PFOS transport has not been tested. In summary, Cyp2b-null and hCYP2B6-Tg mice provided unique models for estimating the importance of novel mechanisms in PFOS retention and toxicity.
全氟辛烷磺酸(PFOS)是一种广泛存在的环境污染物,半衰期长,对脂肪肝疾病和糖尿病等代谢性疾病具有明显的负面影响。对雄性和雌性Cyp2b基因敲除小鼠以及人源化CYP2B6转基因(hCYP2B6-Tg)小鼠,分别用0、1或10毫克/千克/天的PFOS处理21天,令人惊讶的是,发现PFOS在hCYP2B6-Tg小鼠血清和肝脏中的浓度高于Cyp2b基因敲除小鼠,且在雌性小鼠中差异更大。因此,Cyp2b基因敲除小鼠和hCYP2B6-Tg小鼠为研究PFOS生物累积和毒性的个体机制提供了新模型。以死亡率衡量,hCYP2B6-Tg小鼠(尤其是雌性)的明显毒性更大;然而,尽管PFOS在肝脏中的浓度较低,但脂肪变性在Cyp2b基因敲除小鼠中更容易发生。对经PFOS处理的Cyp2b基因敲除小鼠和hCYP2B6-Tg小鼠肝脏进行靶向脂质组学和转录组学分析,并使用主成分分析(PCA)将其与PFOS保留情况和毒性血清标志物进行比较。几种氧化脂质,包括前列腺素、血栓素和二十二碳六烯酸代谢物,与PFOS毒性相关或呈负相关。脂质组学和转录组学均表明,在所有模型中PFOS毒性都与过氧化物酶体增殖物激活受体(PPAR)活性相关。与脂肪变性减轻相关的基因本体(GO)术语具有性别二态性,雌性中脂质代谢和转运增加,雄性中与昼夜节律相关的基因增加。然而,我们不能排除脂肪变性最初对PFOS毒性具有保护作用。此外,几种转运蛋白与PFOS保留增加有关,这可能是由于摄取增加所致。最强的关联是有机阴离子转运蛋白()基因和一种长链脂肪酸转运蛋白(),在雌性hCYP2B6-Tg小鼠中富集。OATP抑制剂也降低了培养的小鼠肝细胞对PFOS的摄取。OATP1A6和FATP1在PFOS转运中的作用尚未得到测试。总之,Cyp2b基因敲除小鼠和hCYP2B6-Tg小鼠为评估新机制在PFOS保留和毒性中的重要性提供了独特模型。